Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Combination formula for regulating surface mucous layer barriers of digestive tract and respiratory tract

A pipeline and mucus technology, which is applied in the field of combination formulations of Chinese medicinal materials and amino acids, can solve problems such as large side effects and unsatisfactory effects, achieve good therapeutic effects, enhance blood supply and oxygen supply, and prevent abnormal immune responses.

Inactive Publication Date: 2016-05-18
何松庆
View PDF1 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

The above-mentioned treatment measures are unsatisfactory in effect and have large side effects

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Examples

Experimental program
Comparison scheme
Effect test

Embodiment Construction

[0029] 1. 5 grams of ganoderma lucidum, 3.0 grams of American ginseng, 0.5 grams of threonine, 0.6 grams of serine, 0.03 grams of cysteine, and 0.03 grams of cystine are made into oral doses, 2 to 4 times a day.

[0030] 2. 2.5 grams of ganoderma lucidum, 1.5 grams of American ginseng, 0.25 grams of threonine, 0.3 grams of serine, 0.015 grams of cysteine, and 0.015 grams of cystine are made into oral preparations, 2 to 4 times a day.

[0031] 3. 5 grams of ganoderma lucidum, 3.0 grams of American ginseng, 0.5 grams of threonine, 0.6 grams of serine, and 0.06 grams of cysteine ​​are made into oral agents, 2 to 4 times a day.

[0032] 4. 2.5 grams of Ganoderma lucidum, 1.5 grams of American ginseng, 0.25 grams of threonine, 0.3 grams of serine, and 0.03 grams of cysteine ​​are made into oral agents, 2 to 4 times a day.

[0033] 5. 5 grams of ganoderma lucidum, 3.0 grams of American ginseng, 0.5 grams of threonine, 0.6 grams of serine, and 0.06 grams of cystine are made into oral...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention discloses a combination formula for regulating surface mucous layer barriers of the digestive tract and the respiratory tract, and belongs to the field of medicine. The combination formula comprises ganoderma lucidum, American ginseng, threonine, serine, cysteine and cystine. ganoderma lucidum and American ginseng have the effects of enhancing human body blood supply and oxygen supply, and threonine, serine and cysteine serve as main ingredients for composing mucoprotein. The combination formula provides nutrition, oxygen and raw materials for generating, updating and repairing of mucous cells such as goblet cells and mucous glands of the digestive tract and the respiratory tract and mucoprotein secreting. The combination formula is an effective combination formula for constructing the normal surface mucous layer barriers of the digestive tract and the respiratory tract of a human body, preventing antigens from approaching, making contact with, adhering to and entering tissue of the digestive tract and the respiratory tract, blocking abnormal immune responses, terminating inflammations, repairing the tissue of the digestive tract and the respiratory tract and preventing and treating diseases of a digestive system and a respiratory system.

Description

technical field [0001] The invention relates to a combined formula of Chinese medicinal materials and amino acids, belonging to the field of medicines. Background technique [0002] Most human diseases occur or originate in the digestive system and respiratory system, especially inflammatory bowel disease (inflammatory bowel disease (IBD), irritable bowel syndrome (IBS) in the digestive system and chronic bronchitis (chronicbronchitis) in the respiratory system. Asthma (bronchialasthma) and other diseases whose etiology and pathogenesis have not yet been fully clarified. Since the cause and pathogenesis of these diseases have not been fully elucidated, people cannot fundamentally prevent or delay the progress of the course of these diseases. [0003] Inflammatory bowel disease (inflammatory bowel disease, IBD) is a disease whose etiology and pathogenesis have not yet been fully clarified. [0004] Medical immunology believes that the immune system has abnormal recognition ...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
IPC IPC(8): A61K36/258A61P1/00A61P11/00A61P11/06A61K31/198
CPCA61K36/258A61K9/0056A61K31/198A61K36/074A61K2300/00
Inventor 何松庆
Owner 何松庆
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com